Healthpeak Properties, Inc. (NYSE:DOC) Receives $23.45 Average Target Price from Analysts

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have earned a consensus rating of “Moderate Buy” from the eleven analysts that are covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $23.45.

A number of equities research analysts have recently weighed in on DOC shares. Argus restated a “buy” rating and set a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Evercore ISI lowered their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Robert W. Baird decreased their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Tuesday, April 29th. Wedbush decreased their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Finally, Scotiabank cut their target price on Healthpeak Properties from $23.00 to $21.00 and set a “sector outperform” rating on the stock in a research report on Monday, May 12th.

Insider Activity at Healthpeak Properties

In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,700 shares of the business’s stock in a transaction that occurred on Friday, May 9th. The stock was purchased at an average price of $17.36 per share, for a total transaction of $98,952.00. Following the purchase, the director now directly owns 138,513 shares in the company, valued at approximately $2,404,585.68. This trade represents a 4.29% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Scott M. Brinker purchased 11,337 shares of the business’s stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average price of $17.68 per share, with a total value of $200,438.16. Following the purchase, the chief executive officer now owns 201,863 shares in the company, valued at $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 23,987 shares of company stock worth $422,141. 0.23% of the stock is owned by corporate insiders.

Institutional Trading of Healthpeak Properties

Institutional investors have recently bought and sold shares of the business. Barclays PLC acquired a new position in Healthpeak Properties during the third quarter worth $35,078,000. JPMorgan Chase & Co. increased its stake in shares of Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock worth $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. AdvisorNet Financial Inc increased its stake in shares of Healthpeak Properties by 34.5% during the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 563 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in shares of Healthpeak Properties by 18.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 29,143 shares of the real estate investment trust’s stock worth $591,000 after purchasing an additional 4,446 shares in the last quarter. Finally, Park Avenue Securities LLC boosted its holdings in Healthpeak Properties by 11.6% in the 4th quarter. Park Avenue Securities LLC now owns 24,700 shares of the real estate investment trust’s stock worth $501,000 after buying an additional 2,567 shares during the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Stock Down 1.3%

Shares of Healthpeak Properties stock opened at $17.49 on Friday. The company has a market cap of $12.15 billion, a P/E ratio of 49.97, a PEG ratio of 2.17 and a beta of 1.05. Healthpeak Properties has a 52-week low of $16.90 and a 52-week high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm’s 50 day moving average price is $18.68 and its 200-day moving average price is $19.99.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. During the same quarter in the prior year, the business posted $0.45 EPS. The business’s revenue for the quarter was up 15.9% compared to the same quarter last year. On average, sell-side analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be issued a $0.1017 dividend. The ex-dividend date is Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 305.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.